A detailed history of Uss Investment Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 77,495 shares of MRNA stock, worth $3.21 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
77,495
Previous 80,257 3.44%
Holding current value
$3.21 Million
Previous $9.53 Million 45.67%
% of portfolio
0.04%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $175,773 - $345,636
-2,762 Reduced 3.44%
77,495 $5.18 Million
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $226,811 - $373,373
2,241 Added 2.87%
80,257 $9.53 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $737,084 - $996,708
8,634 Added 12.44%
78,016 $8.31 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $208,530 - $313,290
-3,000 Reduced 4.14%
69,382 $6.9 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.01 Million - $1.33 Million
10,508 Added 16.98%
72,382 $7.48 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $84,923 - $123,334
-626 Reduced 1.0%
61,874 $9.5 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $315,601 - $559,966
-2,666 Reduced 4.09%
62,500 $11.2 Million
Q3 2022

Nov 08, 2022

SELL
$118.07 - $194.18 $2.12 Million - $3.48 Million
-17,939 Reduced 21.59%
65,166 $7.71 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $802,926 - $1.21 Million
-6,855 Reduced 7.62%
83,105 $11.9 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $1.65 Million - $3.07 Million
13,046 Added 16.96%
89,960 $15.5 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $2.21 Million - $4.82 Million
9,956 Added 14.87%
76,914 $29.6 Million
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $6.55 Million - $11.2 Million
59,958 Added 856.54%
66,958 $8.77 Million
Q2 2020

Aug 11, 2020

BUY
$29.67 - $80.0 $207,690 - $560,000
7,000 New
7,000 $450,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.